JULPHAR was established in the year 1980 in the United Arab Emirates, as a public joint stock company, it is currently one of the largest pharmaceutical manufacturers in the Middle East and North Africa, distributing medicine in more than 40 Countries. The company has factories in the United Arab Emirates specialized in producing pills, solutions and suspensions. The company also established several factories in Ethiopia, Bangladesh and Saudi Arabia as part of its continuous global expansion strategy. JULPHAR's capital amounts to AED 1.159 billion, of which ACDIMA owns 9.1509%.